TL;DR

MarketBeat All Access is a decent paid layer for analyst ratings, insider trades and dividend alerts, but at a listed $399 per year it only beats the free tier if you use the screeners and exports weekly; it is a research feed, not a stock picker.

Key Takeaways

  • 1.MarketBeat's own pages list All Access at $399 per year or about $39.97 per month, while some third-party sites show $249 per year, so confirm the price at checkout.
  • 2.The free tier already gives you a ten-stock watchlist, the Daily Ratings newsletter, and basic stock and dividend screeners.
  • 3.Paid access adds the Analyst Ratings and Insider Transactions screeners, a live news feed, alerts and data exports.
  • 4.Its strength is aggregated ratings, insider and dividend data, not valuation models or charting.
  • 5.I found no confirmed free trial terms, so check the subscribe page before paying.

MarketBeat is a stock research site that aggregates analyst ratings, insider transactions, dividends and earnings data, and its paid All Access plan lists at $399 per year in 2026. It is worth buying only if you act on ratings and insider flow weekly. Casual investors can stay on the free tier.

I reviewed MarketBeat's own help and pricing pages and compared them with third-party listings, which disagree on price. Where sources conflict, I say so below instead of guessing. Expect a plain breakdown of what is free, what is paid, who benefits, and which tools beat it for specific jobs.

What is MarketBeat and is it legit?

MarketBeat is a legitimate financial data site that collects analyst rating changes, price targets, insider buying and selling, dividend announcements and earnings dates for US stocks. It is a data aggregator and news publisher, not a broker or an adviser, and it does not manage money or promise returns.

The site's value is speed and consolidation. Instead of checking SEC Form 4 filings, brokerage notes and company calendars separately, you see them on one page per ticker. That saves time for people who track a watchlist of dozens of names.

What it does not do is tell you which stock to buy. Analyst ratings are opinions, and price targets are often revised after the stock has already moved. Treat the feed as input to your own process.

Ratings are not recommendations

A consensus of Buy ratings tells you what analysts think, not what the stock will do. Always combine rating data with your own valuation and risk limits.

MarketBeat is a data aggregator for analyst ratings, insider trades and dividends, and it is not an adviser or a source of trade signals.

How much does MarketBeat cost in 2026?

MarketBeat's own subscribe page and FAQ list All Access at $399 per year, with a monthly option near $39.97. Several third-party comparison sites show $249 per year or $29 per month, and a MarketBeat press page has described All Access returning to $249 as a time-limited sale, so promotions clearly happen.

SourceAnnual priceMonthly priceNote
MarketBeat subscribe page and FAQ$399About $39.97Standard listed price
MarketBeat press page$249Not statedTime-limited sale pricing
FindMyMoat listing$249$29Third-party, may show promotions
TradingTools listing$299 first yearNot statedClaims renewal at $499, conflicts with official page

I treat the $399 figure as the standard rate because it comes from the vendor's own pages, and I do not rely on the $499 renewal claim since it conflicts with the official number. If you see a $249 offer, check the end date and the renewal price before you click.

At $399 per year, All Access costs about $33 per month. The monthly plan at $39.97 costs $479.64 per year, so annual billing saves roughly $80, which matches the savings figure shown on the subscribe page.

The only way to know your true cost is the checkout screen, because MarketBeat's listed price runs from $249 to $399 per year depending on the promotion.

What do you get for free versus All Access?

The free tier is generous. It includes the Daily Ratings newsletter, a watchlist of up to ten stocks, basic company research, stock comparison and basic stock and dividend screeners. For many long-term investors that covers most of the daily need.

All Access adds the tools that heavy users want. According to MarketBeat's help page, the paid plan includes advanced research tools, a live news feed and extended export options, and the Analyst Ratings and Insider Transactions screeners sit behind the paywall.

FeatureFreeAll Access
Daily Ratings newsletterYesYes
WatchlistUp to 10 stocksLarger tracking and alerts
Stock and dividend screenersYesYes
Analyst Ratings screenerNoYes
Insider Transactions screenerNoYes
Live news feedNoYes
Excel or CSV exportsLimitedYes, reportedly up to six months of history
Alerts on ratings, dividends, earnings, insidersBasicYes

The practical test is simple. If you open the ratings and insider screeners at least once a week, the paid plan is working for you. If you only read the newsletter, you already have what you need.

MarketBeat gives free users a ten-stock watchlist and basic screeners, and the $249 to $399 per year upgrade mainly buys the analyst and insider screeners, alerts and exports.

Is MarketBeat accurate and useful for finding trades?

The data is sourced from public filings and brokerage rating changes, so it is generally reliable for what happened, such as a downgrade or an insider sale. The weakness is timing. Ratings and Form 4 filings arrive after the event, so you are reacting, not predicting.

Insider data is the best use case. Cluster buying by several executives at one company is a signal many investors watch, and an insider screener makes that search fast. Selling is noisier, because executives sell for tax and diversification reasons that have nothing to do with the outlook.

A weekly MarketBeat workflow

  1. 1

    Scan the ratings screener

    Filter for upgrades in your watchlist sectors and note any stock with two or more rating changes in the same week.

  2. 2

    Check insider transactions

    Look for open-market purchases, not option exercises or scheduled sales, and note the dollar size relative to the executive's pay.

  3. 3

    Verify with filings

    Open the original SEC filing to confirm the numbers before you act on a headline.

  4. 4

    Validate with valuation

    Run the idea through your own valuation or a tool like Koyfin or Stock Rover before sizing a position.

  5. 5

    Set alerts

    Add the tickers that pass to your alert list so you hear about the next rating or dividend change.

A concrete example shows the point. Say three directors at a mid-cap company each buy $50,000 of stock on the open market within ten days. That is $150,000 of fresh money, and it is the kind of cluster the Insider Transactions screener surfaces in seconds. A single director selling $2 million of stock after an option vest tells you far less, because the sale is often pre-scheduled.

Analyst data needs similar care. A price target raised from $120 to $135 sounds bullish, but if the stock already trades at $138 the change is a catch-up, not a forecast. Always compare the new target with the current price and with the prior rating date before you treat it as news.

I would not trade on a MarketBeat headline alone. Use it to build a shortlist, then verify with filings and valuation.

MarketBeat tells you what analysts and insiders did after the fact, so it is best used to build a shortlist and not as a trigger for trades.

How does MarketBeat compare with other research tools?

MarketBeat sits in the analyst and insider data niche. It is lighter than Koyfin on charting and financial statements, narrower than Seeking Alpha on written analysis, and cheaper than many terminals. Its edge is the dividend and ratings calendar, which suits income investors.

If you want valuation and screening depth, tools like Stock Rover, Koyfin or Finviz Elite fit better. If you want charts, TradingView is the standard. If you want long-form analyst opinion, Seeking Alpha is the usual pick. MarketBeat works as a complement to those, not a replacement.

Pros

  • Consolidates ratings, insider trades, dividends and earnings in one place.
  • Useful free tier with watchlist and basic screeners.
  • Alerts for ratings changes, dividends, earnings and insider activity.
  • Data exports for people who work in spreadsheets.

Cons

  • Listed price of $399 per year is high for what is mostly aggregated data.
  • Prices vary by source and promotion, which makes budgeting confusing.
  • No confirmed free trial terms found.
  • Limited charting and no deep valuation models.
  • Data reports events after they happen.

Exports matter more than they sound. Pulling six months of ratings changes into a spreadsheet lets you count how often a given analyst firm upgrades before a rally, or how many rating changes a sector saw in a quarter. That kind of own-research work is where a paid data feed earns its keep, and where the free tier runs out.

MarketBeat complements charting and valuation tools instead of replacing them, so judge it on whether the ratings and insider screeners save you real research time.

Who should buy MarketBeat All Access?

Buy it if you are an income investor who tracks dividend dates, or an active investor who screens insider buying every week. At $249 it is an easy yes for those users. At $399 it is a closer call, and you should count how many hours per week it saves.

Dividend investors get the clearest return on the subscription. A calendar of announced dividends, ex-dividend dates and payout changes across a 30-stock income portfolio is tedious to build by hand, and alerts remove the risk of missing an ex-dividend date by a day. If one missed date costs you a $200 payment, the annual fee looks smaller.

Skip it if you invest through index funds, check your portfolio monthly, or already pay for a research suite that includes ratings data. Also skip it if you expect trade signals. It will not hand you ideas with a guaranteed outcome.

  • I open ratings or insider data at least once a week.
  • I track more than ten stocks, so the free watchlist is too small.
  • I export data to a spreadsheet for my own analysis.
  • I value dividend and earnings alerts enough to pay about $33 per month.
  • I have confirmed the current price and renewal terms at checkout.

If you tick at least four of those boxes, All Access probably pays for itself in saved research time, and if you tick fewer, stay on the free tier.

The verdict

MarketBeat is a solid, honest data aggregator with a useful free tier and a paid plan that suits a narrow audience. The $399 per year list price is high when promotions at $249 appear regularly, so wait for a sale if you are not in a hurry, and read the renewal terms.

My advice is to run the free version for a month first. Use the ten-stock watchlist and the Daily Ratings newsletter, and note how often you wish you could filter by insider buying or analyst changes. If that happens every week, upgrade. If it never does, you just saved at least $249 per year.

Pair it with a charting platform and a valuation tool, and treat ratings as a starting point for your own work. Verify every insider headline against the original filing.

MarketBeat All Access is worth $249 to $399 per year only for investors who screen analyst and insider data weekly, and everyone else is well served by the free tier.

Get smarter trades, weekly

One short email every Sunday. AI workflows, tool reviews, and trader productivity tips.